VBID improves adherence by eliminating financial barriers to obtaining medication. The study examined Blue Cross Blue Shield of North Carolina’s VBID program, which started in 2008.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Patients in the study experienced lowered or eliminated payments for some medications. Despite better adherence, however, improved disease management did not lower cost as was expected to occur. In addition while hospital admissions decreased, emergency department use and health expenditures did not decrease.
Researchers suggests VBID isn’t cost neutral in the short term, and long-term studies are necessary to determine the effect of the practice over time.
More Articles on Quality:
HRET Network Saves $202M, Improves Care for 69,000 Patients
6 Strategies for Reducing Health Service Overuse
HHS Recognizes Best Hypertension Practices, Health Systems
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
